Paragon 28 to Present at the CG 2024 Musculoskeletal Conference
Paragon 28, Inc. (NYSE: FNA) will have its Chairman and CEO, Albert DaCosta, and CFO, Steve Deitsch, participate in a fireside chat at the CG 2024 Musculoskeletal Conference. The event will take place on February 12, 2024, at 1:00 p.m. PT / 2:00 p.m. MT. A live webcast and archived recording will be accessible on the company's investor relations website.
02/12/2024 - 11:36 AM
ENGLEWOOD, Colo. --(BUSINESS WIRE)--
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will participate in a fireside chat at the CG 2024 Musculoskeletal Conference on Monday, February 12, 2024, at 1:00 p.m. Pacific Time / 2:00 p.m. Mountain Time.
A live webcast, as well as the archived recording, will be available on the investor relations section of the Company’s website at ir.paragon28.com.
About Paragon 28, Inc.
Based in Englewood, Colo. , Paragon 28, is a leading medical device company exclusively focused on the foot and ankle orthopedic market and is dedicated to improving patient lives. From the onset, Paragon 28® has provided innovative orthopedic solutions, procedural approaches and instrumentation that cover a wide range of foot and ankle ailments including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, charcot foot and orthobiologics. The company designs products with both the patient and surgeon in mind, with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent, and reproducible.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240212035547/en/
Investor Contact:
Matt Brinckman
Senior Vice President, Strategy and Investor Relations
(720) 912-1332
mbrinckman@paragon28.com
Source: Paragon 28, Inc.
When will the fireside chat at the CG 2024 Musculoskeletal Conference take place for Paragon 28, Inc. (NYSE: FNA)?
The fireside chat is scheduled for Monday, February 12, 2024, at 1:00 p.m. Pacific Time / 2:00 p.m. Mountain Time.
Who will be participating in the fireside chat at the CG 2024 Musculoskeletal Conference for Paragon 28, Inc. (NYSE: FNA)?
Albert DaCosta, Chairman and CEO, and Steve Deitsch, CFO, will be participating in the fireside chat.
Where can the live webcast and archived recording of the fireside chat be accessed for Paragon 28, Inc. (NYSE: FNA)?
The live webcast and archived recording will be available on the investor relations section of the company's website at ir.paragon28.com.
FNA Rankings
#4883 Ranked by Stock Gains
FNA Stock Data
Industry
Surgical and Medical Instrument Manufacturing
Sector
Manufacturing
Country
US
City
Englewood
About FNA
paragon 28 was established in 2010 as an orthopedic foot and ankle company. the name “paragon 28” was chosen to show that we are exclusively a foot and ankle company, with the “28” representing the number of bones in the foot. we will remain true to that vision. paragon 28 was started as a small, family-based company and we have kept those core ideals as we have grown. our mission is to strategically build a company around the core principles that drive innovation and quality. relentlessly working to advance the science behind foot and ankle surgery, paragon 28 is passionate about and committed to: - creation and innovation: blending different surgical philosophies from various global thought leaders to develop bio-mechanically and clinically relevant surgical solutions. - a focus on service: a customer service based, dedicated, and highly trained distribution network to the foot and ankle market. - efficient practices: meeting the needs of increasing pricing pressures and reimbursemen